Sunshine Biopharma Inc. — Form 8-K
Filed October 14, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Sunshine Biopharma Inc. filed Form 8-K on 2026-10-14 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) for period ending 2026-10-13. The filing contains no substantive disclosure of voting details, counterparties, amounts, or outcomes — only metadata and XBRL formatting exhibits.
Why this rating
Filing is routine procedural disclosure with no material facts disclosed. Cannot assess business impact without vote details.
Extracted items
See more from October 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.